You have 9 free searches left this month | for more free features.

7 3 chemotherapy

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Acute Myeloid Leukemia, Mixed Lineage Acute Leukemia, Mixed Lineage Leukemia Gene Mutation Trial (Ziftomenib, Venetoclax,

Not yet recruiting
  • Acute Myeloid Leukemia
  • +10 more
  • (no location specified)
Feb 17, 2023

Acute Myeloid Leukemia, Myelodysplastic Tumor Trial (Magrolimab, 7+3, CPX-351)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Neoplasm
  • (no location specified)
Apr 24, 2023

AML, Adult, Chemo Effect Trial in Suzhou (Venetoclax, Decitabine for Injection, Cytarabine)

Recruiting
  • AML, Adult
  • Chemotherapy Effect
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University, Jiangsu Ins
Feb 28, 2022

Gastric Adenocarcinoma, Oligometastasis, Stage IV Esophageal Adenocarcinoma AJCC v7 Trial in Houston (drug, procedure,

Recruiting
  • Gastric Adenocarcinoma
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 20, 2022

Rectal Cancer Trial in Canada, United States (Folfox Protocol, Capox)

Active, not recruiting
  • Rectal Cancer
  • Orange, California
  • +10 more
Aug 22, 2022

OBSERVATIONAL STUDY OF AVELUMAB AS FIRST-LINE MAINTENANCE

Recruiting
  • Urothelial Cancer
  • Bristol, United Kingdom
  • +9 more
Jan 23, 2023

Localized Osteosarcoma, Metastatic Osteosarcoma, Resectable Osteosarcoma Trial (Bone Scan, Cabozantinib S-malate, Cisplatin)

Not yet recruiting
  • Localized Osteosarcoma
  • +3 more
  • Cabozantinib S-malate
  • +7 more
  • (no location specified)
Jan 4, 2023

NSCLC Trial in Canada (Osimertinib First-Line, Platinum + Pemetrexed Chemotherapy Second-Line, Osimertinib Third-Line)

Recruiting
  • Non-Small Cell Lung Cancer
  • Osimertinib First-Line
  • +2 more
  • Vancouver, British Columbia, Canada
  • +9 more
Jun 21, 2022

Diffuse Large B Cell Lymphoma Trial (Pembrolizumab, Rituximab, Ifosfamide)

Recruiting
  • Diffuse Large B Cell Lymphoma
  • Headington, Oxford, United Kingdom
  • +1 more
Nov 2, 2022

Metastatic Colorectal Carcinoma, Metastatic Malignant Tumor in the Liver, Stage IV Colorectal Cancer AJCC v8 Trial (biological,

Not yet recruiting
  • Metastatic Colorectal Carcinoma
  • +3 more
  • Bevacizumab
  • +11 more
  • (no location specified)
May 9, 2023

Metastatic NSCLC Trial in Worldwide (Volrustomig, Pembrolizumab, Carboplatin)

Not yet recruiting
  • Metastatic Non-small Cell Lung Cancer
  • Rosario, Argentina
  • +51 more
Aug 2, 2023

Newly Diagnosed Acute Myeloid Leukemia (AML) Trial in Chengdu (SKLB1028 Dose Escalation)

Recruiting
  • Newly Diagnosed Acute Myeloid Leukemia (AML)
  • SKLB1028 Dose Escalation
  • Chengdu, China
    West China Hospital of Sichuan University
Jun 30, 2022

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8

Recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +12 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 16, 2022

Stage III Cutaneous Melanoma AJCC v7, Stage IIIA Cutaneous Melanoma AJCC v7, Stage IIIB Cutaneous Melanoma AJCC v7 Trial in

Completed
  • Stage III Cutaneous Melanoma AJCC v7
  • +5 more
  • Aldesleukin
  • +4 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 17, 2022

Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, HER2-Negative Breast Carcinoma Trial in

Not yet recruiting
  • Anatomic Stage II Breast Cancer AJCC v8
  • +3 more
  • Biospecimen Collection
  • +7 more
  • Portland, Oregon
    SWOG
Sep 27, 2023

Ovarian Cancer Trial in United Kingdom (Olaparib, Cediranib, Paclitaxel)

Active, not recruiting
  • Ovarian Cancer
  • Belfast, County Antrim, United Kingdom
  • +13 more
Feb 22, 2022

Platinum-resistant Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Canada, United States (Nemvaleukin

Recruiting
  • Platinum-resistant Ovarian Cancer
  • +2 more
  • Nemvaleukin and Pembrolizumab Combination
  • +6 more
  • Ventura, California
  • +7 more
Aug 5, 2022

Acute Myeloid Leukemia (AML) Trial in Worldwide (standard combination chemo, decitabine)

Active, not recruiting
  • Acute Myeloid Leukemia (AML)
  • Edegem, Antwerpen, Belgium
  • +52 more
Sep 13, 2022

Carcinosarcoma, Endometrial Tumors Trial in United Kingdom (Paclitaxel, Cediranib, Olaparib)

Active, not recruiting
  • Carcinosarcoma
  • Endometrial Neoplasms
  • Northwood, Middlesex, United Kingdom
  • +14 more
Feb 10, 2022

Disease State in Adult Acute Myeloid Leukemia Ineligible for

Not yet recruiting
  • Acute Myeloid Leukemia
    • Calgary, Alberta, Canada
    • +9 more
    Jun 15, 2022

    Metastatic Colon Carcinoma, Metastatic Colorectal Carcinoma, Metastatic Rectal Carcinoma Trial in United States (Laboratory

    Active, not recruiting
    • Metastatic Colon Carcinoma
    • +24 more
    • Laboratory Biomarker Analysis
    • +2 more
    • Corona, California
    • +7 more
    Oct 26, 2022

    Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer Stage IV, Pancreatic Cancer Non-resectable Trial in Oxford (Focused

    Recruiting
    • Pancreatic Ductal Adenocarcinoma
    • +3 more
    • Focused Ultrasound
    • +2 more
    • Oxford, United Kingdom
      Oxford University Hospitals NHS Trust
    Feb 22, 2022

    Colorectal Adenocarcinoma, Colorectal Carcinoma Metastatic in the Lung, Stage IV Colorectal Cancer AJCC v8 Trial in Canada,

    Recruiting
    • Colorectal Adenocarcinoma
    • +5 more
    • Boston, Massachusetts
    • +7 more
    Apr 19, 2022

    Metastatic Melanoma, Stage IIIB Cutaneous Melanoma AJCC v7, Stage IIIC Cutaneous Melanoma AJCC v7 Trial in Houston (biological,

    Completed
    • Metastatic Melanoma
    • +3 more
    • Aldesleukin
    • +6 more
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 27, 2022

    Lung Cancer Metastatic Trial in Australia, Canada (Durvalumab, Tremelimumab, Platinum-Based Drug)

    Active, not recruiting
    • Lung Cancer Metastatic
    • Campbelltown, New South Wales, Australia
    • +48 more
    Jun 23, 2022